Your session is about to expire
← Back to Search
CBD + THC for HIV/AIDS (CAMI Trial)
CAMI Trial Summary
This trial will study the effects of cannabis use and HIV on the brain and inflammation. Participants will be given the same treatment in a different order over 6 weeks to monitor safety and measure the effects of the drug.
CAMI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCAMI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CAMI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can understand and agree to medical assessments.I do not have severe depression, psychosis, or thoughts of suicide.I have not used cannabis or only used it once in the last 2 weeks.My liver or kidney function is moderately to severely impaired.I am between 21 and 70 years old.I have a history of liver-related illness with high liver enzyme and bilirubin levels.I am not allergic to the study drugs or any of their ingredients, including sesame.I do not have a neurological condition that could affect the study's results.I weigh less than 60 kg.I am currently taking medication that makes me sleepy.I have a heart condition or uncontrolled high blood pressure.I am not on medications that could dangerously interact with the trial treatment.I have used cannabis in the last 5 years without severe side effects.I need extra oxygen due to a long-term lung condition.I am HIV positive, on stable treatment for 6+ months, with a good immune level and no major treatment issues.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Are there still available slots for those wishing to partake in this research?
"Per the information posted on clinicaltrials.gov, this research is not actively recruiting participants at present. The trial was first announced October 1st 2022 and last updated September 14th of that same year. Even though this investigation has halted recruitment for now, there are still 450 other studies seeking volunteers presently."
Has the Food and Drug Administration sanctioned THC for medicinal use?
"In our assessment, THC's safety was rated a 2 due to its Phase 2 trial status. This indicates that there is some information on the drug's security but none demonstrating effectiveness."
Share this study with friends
Copy Link
Messenger